IDEAYA Biosciences, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -180.90%-179.91%-122.72%-574.85%-4,671.07%
EBIT Margin -180.90%-179.91%-122.72%-574.85%-4,671.07%
EBITDA Margin -176.85%-180.67%-119.40%-468.37%-3,917.53%
Operating Margin -180.90%-179.91%-122.72%-574.85%-4,671.07%
Net Margin -180.90%-179.91%-122.72%-574.85%-4,671.07%
FCF Margin 281.21%-209.09%-177.92%-502.85%-3,592.01%
Efficiency
Assets Average 205.63M339.81M384.66M518.64M886.70M
Equity Average 149.34M249.89M325.48M485.27M840.12M
Invested Capital 100.40M198.27M301.51M349.45M621.09M1,059.15M
Asset Utilization Ratio 0.100.080.130.050.01
Leverage & Solvency
Equity Ratio 0.890.660.790.900.960.94
Valuation
Enterprise Value 53.53M123.39M663.31M509.39M1,768.35M1,544.98M
Market Capitalization 152.48M406.98M910.08M874.22M2,293.47M2,221.30M
Return Ratios
Return on Sales -1.81%-1.80%-1.23%-5.75%-46.71%
Return on Capital Employed -0.21%-0.17%-0.18%-0.27%-0.39%
Return on Assets -0.17%-0.15%-0.16%-0.26%-0.37%
Return on Equity -0.24%-0.20%-0.19%-0.28%-0.39%